EGF and non-small cell lung carcinoma: Erlotinib is a well-known inhibitor of Epidermal Growth Factor (EGF) receptor (UniProtKB P00533) used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer (Schettino et al., 2008).